Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 (Q64123004)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 |
clinical trial |
Statements
EE-ASI-1 (English)
0 references
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 (EE-ASI-1): A Phase 1a Study of Gold Nanoparticles Administered Intradermally by Microneedles to Deliver Immunotherapy With a Proinsulin Derived Peptide in Type 1 Diabetes (English)
0 references
29 September 2016
0 references
31 January 2020
0 references
8
0 references
16 year
0 references
40 year
0 references